BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 25044437)

  • 1. Molecular recognition of two 2,4-syn-functionalized (S)-glutamate analogues by the kainate receptor GluK3 ligand binding domain.
    Venskutonytė R; Larsen AP; Frydenvang K; Gajhede M; Sagot E; Assaf Z; Gefflaut T; Pickering DS; Bunch L; Kastrup JS
    ChemMedChem; 2014 Oct; 9(10):2254-9. PubMed ID: 25044437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding site and interlobe interactions of the ionotropic glutamate receptor GluK3 ligand binding domain revealed by high resolution crystal structure in complex with (S)-glutamate.
    Venskutonytė R; Frydenvang K; Gajhede M; Bunch L; Pickering DS; Kastrup JS
    J Struct Biol; 2011 Dec; 176(3):307-14. PubMed ID: 21907808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and Affinity of Two Bicyclic Glutamate Analogues at AMPA and Kainate Receptors.
    Møllerud S; Pinto A; Marconi L; Frydenvang K; Thorsen TS; Laulumaa S; Venskutonytė R; Winther S; Moral AMC; Tamborini L; Conti P; Pickering DS; Kastrup JS
    ACS Chem Neurosci; 2017 Sep; 8(9):2056-2064. PubMed ID: 28691798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoenzymatic synthesis of new 2,4-syn-functionalized (S)-glutamate analogues and structure-activity relationship studies at ionotropic glutamate receptors and excitatory amino acid transporters.
    Assaf Z; Larsen AP; Venskutonytė R; Han L; Abrahamsen B; Nielsen B; Gajhede M; Kastrup JS; Jensen AA; Pickering DS; Frydenvang K; Gefflaut T; Bunch L
    J Med Chem; 2013 Feb; 56(4):1614-28. PubMed ID: 23414088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological and structural characterization of conformationally restricted (S)-glutamate analogues at ionotropic glutamate receptors.
    Juknaitė L; Venskutonytė R; Assaf Z; Faure S; Gefflaut T; Aitken DJ; Nielsen B; Gajhede M; Kastrup JS; Bunch L; Frydenvang K; Pickering DS
    J Struct Biol; 2012 Oct; 180(1):39-46. PubMed ID: 22789682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kainate induces various domain closures in AMPA and kainate receptors.
    Venskutonytė R; Frydenvang K; Hald H; Rabassa AC; Gajhede M; Ahring PK; Kastrup JS
    Neurochem Int; 2012 Sep; 61(4):536-45. PubMed ID: 22425692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N1-Substituted Quinoxaline-2,3-diones as Kainate Receptor Antagonists: X-ray Crystallography, Structure-Affinity Relationships, and in Vitro Pharmacology.
    Pallesen J; Møllerud S; Frydenvang K; Pickering DS; Bornholdt J; Nielsen B; Pasini D; Han L; Marconi L; Kastrup JS; Johansen TN
    ACS Chem Neurosci; 2019 Mar; 10(3):1841-1853. PubMed ID: 30620174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Structure of a High-Affinity Kainate Receptor: GluK4 Ligand-Binding Domain Crystallized with Kainate.
    Kristensen O; Kristensen LB; Møllerud S; Frydenvang K; Pickering DS; Kastrup JS
    Structure; 2016 Sep; 24(9):1582-9. PubMed ID: 27524200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assembly and Trafficking of Homomeric and Heteromeric Kainate Receptors with Impaired Ligand Binding Sites.
    Scholefield CL; Atlason PT; Jane DE; Molnár E
    Neurochem Res; 2019 Mar; 44(3):585-599. PubMed ID: 30302614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of the First Highly Selective Antagonist of the GluK3 Kainate Receptor Subtype.
    Chałupnik P; Vialko A; Pickering DS; Hinkkanen M; Donbosco S; Møller TC; Jensen AA; Nielsen B; Bay Y; Kristensen AS; Johansen TN; Łątka K; Bajda M; Szymańska E
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structures of the GluR5 and GluR6 ligand binding cores: molecular mechanisms underlying kainate receptor selectivity.
    Mayer ML
    Neuron; 2005 Feb; 45(4):539-52. PubMed ID: 15721240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand-binding characteristics and related structural features of the expressed goldfish kainate receptors: identification of a conserved disulfide bond and three residues important for ligand binding.
    Wo ZG; Oswald RE
    Mol Pharmacol; 1996 Oct; 50(4):770-80. PubMed ID: 8863821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational design, synthesis and pharmacological evaluation of the (2R)- and (2S)-stereoisomers of 3-(2-carboxypyrrolidinyl)-2-methyl acetic acid as ligands for the ionotropic glutamate receptors.
    Rasmussen JL; Storgaard M; Pickering DS; Bunch L
    ChemMedChem; 2011 Mar; 6(3):498-504. PubMed ID: 21268287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding and selectivity of the marine toxin neodysiherbaine A and its synthetic analogues to GluK1 and GluK2 kainate receptors.
    Unno M; Shinohara M; Takayama K; Tanaka H; Teruya K; Doh-ura K; Sakai R; Sasaki M; Ikeda-Saito M
    J Mol Biol; 2011 Oct; 413(3):667-83. PubMed ID: 21893069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and pharmacological characterization of phenylalanine-based AMPA receptor antagonists at kainate receptors.
    Venskutonytė R; Frydenvang K; Valadés EA; Szymańska E; Johansen TN; Kastrup JS; Pickering DS
    ChemMedChem; 2012 Oct; 7(10):1793-8. PubMed ID: 22407805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and in vitro pharmacology of GluK1 and GluK3 antagonists. Studies towards the design of subtype-selective antagonists through 2-carboxyethyl-phenylalanines with substituents interacting with non-conserved residues in the GluK binding sites.
    Sköld N; Nielsen B; Olsen J; Han L; Olsen L; Madsen U; Kristensen JL; Pickering DS; Johansen TN
    Bioorg Med Chem; 2014 Oct; 22(19):5368-77. PubMed ID: 25172149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and structure-activity relationships of novel phenylalanine-based amino acids as kainate receptors ligands.
    Szymańska E; Chałupnik P; Szczepańska K; Cuñado Moral AM; Pickering DS; Nielsen B; Johansen TN; Kieć-Kononowicz K
    Bioorg Med Chem Lett; 2016 Nov; 26(22):5568-5572. PubMed ID: 27765511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons from crystal structures of kainate receptors.
    Møllerud S; Frydenvang K; Pickering DS; Kastrup JS
    Neuropharmacology; 2017 Jan; 112(Pt A):16-28. PubMed ID: 27236079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural dynamics of the GluK3-kainate receptor neurotransmitter binding domains revealed by cryo-EM.
    Kumari J; Bendre AD; Bhosale S; Vinnakota R; Burada AP; Tria G; Ravelli RBG; Peters PJ; Joshi M; Kumar J
    Int J Biol Macromol; 2020 Apr; 149():1051-1058. PubMed ID: 32006583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (
    Poulie CBM; Larsen Y; Leteneur C; Barthet G; Bjørn-Yoshimoto WE; Malhaire F; Nielsen B; Pin JP; Mulle C; Pickering DS; Bunch L
    ACS Chem Neurosci; 2022 May; 13(10):1580-1587. PubMed ID: 35475632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.